Lexicon Pharmaceuticals Inc. diskutieren
Lexicon Pharmaceuticals Inc.
WKN: A14SSK / Symbol: LXRX / Name: Lexicon PHARM / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,13 €
-4,68 %
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its price target lowered by analysts at Piper Sandler from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (NASDAQ:LXRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Neueste Beiträge
Roth_Capital in Gran Tierra Energy Inc. diskutieren